• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kensing Acquires Vitae Naturals

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    United Plant Savers Launches First Film Festival
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Sabinsa Corporation

    Gencor

    Nutrition21, LLC

    Verdure Sciences
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Sabinsa Corporation

    Gencor

    Nutrition21, LLC

    Verdure Sciences
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Understanding New Medical Device Regulations

    Manufacturers should assess whether their products are subject to reclassification and be aware of associated requirements.

    Understanding New Medical Device Regulations
    Related CONTENT
    • CHPA Hires Two Key Personnel
    • Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    • Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized
    • Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’
    • DSM and Firmenich to Merge to Create Nutrition, Beauty, and Wellness Brand
    By Joerg Gruenwald, analyze & realize ag06.01.18
    Medical devices have long been considered a loophole category for companies that wish to make a health-related promotional claim for food products. As long as the main health effect is not pharmacological (i.e., as long as a mainly physical effect can be argued), or if the effect takes place outside of the body itself (e.g., in the intestinal tract), some notified bodies in some EU countries such as Germany allowed these products to be registered as substance-based Medical Devices.

    The appeal of these products is that they can make true medicinal claims, as opposed to food products that can only claim maintenance of health. This is possible because Medical Devices are not regulated as food products and as such do not fall within the scope of the Health Claims Regulation. Therefore, this route has been an attractive way to evade the occasionally restrictive regulatory environment surrounding health claims—provided the products were registered in Germany, where the interpretation of the Medical Device Directive was particularly lax.

    For most other EU countries, though, Medical Devices were gloves and syringes and the like, so the notified bodies in those countries never signed off on tablets and capsules being Medical Devices, which caused a bit of confusion about the definition of a “Medical Device” in Europe.

    Changing Landscape
    Partly in response to that confusion, the regulatory situation of Medical Devices is now changing. From May 26, 2020, the new Medical Device Regulation (EU) 2017/745) (MDR) will be in force. Since it is a regulation and not a directive, national implementation is required to be as close to the original text as possible, allowing no room for interpretation.

    While there are no radical changes from the old directive, the MDR is more strictly interpreted because of this, closing the loopholes that existed in countries such as Germany.

    One change—and for some it may indeed be radical—is that probiotics are expressly excluded from being considered as Medical Devices. This closes yet another door for these ingredients being able to make health-related claims—a topic that has been covered in this column before and will doubtless be again in the future.

    ‘Substance-Based’ Medical Devices
    Also, the MDR introduces some changes that will affect classification of some Medical Devices, the substance-based ones among them.

    With the new regulation, Rule 21 was introduced for substance-based Medical Devices. According to this rule, devices that are composed of substances, or of combinations of substances, intended to be introduced into the human body—via an orifice or applied to the skin and absorbed, or locally dispersed in the human body—are classified as class III or class IIa and IIb, respectively.

    This means that previously self-classified products that conform to this description will need to be upgraded to a higher-risk class by May 26, 2020; otherwise they can no longer be marketed.
    Broadly speaking, every substance-based device will be affected. Even simple nose sprays containing nothing more than a saline solution, or lozenges that only exert their effect in the mouth cavity will need to be upgraded to class IIa, with the involvement of a notified body.

    Manufacturers of Medical Devices should assess whether their devices are subject to reclassification and be aware of the requirements for the new class (at least class IIa) for substance-based devices. Since class II has other requirements than class I, the Technical Documentation may need to be updated according to the new requirements.

    If the Medical Device in question now falls into the higher risk classes IIb or even III, some more groundwork will be required. Clinical trials according to ISA 14155, and biocompatibility testing according to ISO 10993, may need to be performed.

    Also, a drug authority may need to be consulted in case the intended action of the product is assisted by a pharmacologically active substance. Experienced consultancies such as analyze & realize GmbH will be able to assist with this upgrade.

    There may, however, be cases when the product will no longer be marketable as a Medical Device at all (e.g., if it contains probiotics, or if due to its nature it seems unlikely that a notified body will register the product as such in view of the stricter interpretation of the regulations). In these cases, a strategic decision is required.

    For many substance-based Medical Devices, a viable option to remain on the market is to re-launch as a food supplement, albeit at the expense of the attractive medicinal claims that are possible for Medical Devices. The pros and cons of such a decision should be considered carefully.


    Joerg Gruenwald
    analyze & realize ag

    Dr. Joerg Gruenwald is co-founder of analyze & realize GmbH, a specialized business consulting company and CRO in the fields of nutraceuticals, dietary supplements, herbals and functional food, and author of the PDR for Herbal Medicines. He can be reached at analyze & realize GmbH, Waldseeweg 6, 13467 Berlin, Germany; +49-30-40008100; E-mail: jgruenwald@a-r.com;
    Website: www.analyze-realize.com.
    Related Searches
    • Regulatory
    • Nutraceuticals
    • Testing
    • Functional Food
    Related Knowledge Center
    • World Markets
    • Regulations
    Suggested For You
    CHPA Hires Two Key Personnel CHPA Hires Two Key Personnel
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized
    Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’ Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’
    DSM and Firmenich to Merge to Create Nutrition, Beauty, and Wellness Brand DSM and Firmenich to Merge to Create Nutrition, Beauty, and Wellness Brand
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    FDA Requests Mandatory Product Listing in 2023 Budget Proposal FDA Requests Mandatory Product Listing in 2023 Budget Proposal
    Canyon Labs Opens Full-Service Laboratory Canyon Labs Opens Full-Service Laboratory
    The Value of Clinical Evidence Supporting Nutraceuticals The Value of Clinical Evidence Supporting Nutraceuticals
    Biden Nominates Dr. Robert Califf to Lead FDA Biden Nominates Dr. Robert Califf to Lead FDA
    CHPA Appoints Duffy MacKay to SVP of Dietary Supplements CHPA Appoints Duffy MacKay to SVP of Dietary Supplements
    Two Science Experts Join Open Book Extracts as Strategic Corporate Advisors Two Science Experts Join Open Book Extracts as Strategic Corporate Advisors
    GRMA Continues Advocacy For Centralized Retailer Standards GRMA Continues Advocacy For Centralized Retailer Standards
    Taking Aim at the Global Heart Health Crisis Taking Aim at the Global Heart Health Crisis
    Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth

    Related Breaking News

    • Breaking News | Dietary Supplements | People News
      CHPA Hires Two Key Personnel

      CHPA Hires Two Key Personnel

      Larisa Pavlick and Kirby Miller will each play strategic roles for the trade association on science-based policy, technical issues, and more.
      06.21.22

    • Dietary Supplements | Regulations
      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Wide-ranging ‘must-pass’ legislation heads to the full Senate for consideration.
      By Mike Montemarano, Associate Editor 06.17.22

    • Dietary Supplements | Mood Health & Sleep | Quality & Safety | Regulations
      Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized

      Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized

      As demand for health and nutrition products continues to grow in a world of hyper stress, it’s important to be clear about FDA’s regulatory authority.
      By Sean Moloughney, Editor 06.02.22


    • Dietary Supplements | Quality & Safety | Regulations
      Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’

      Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’

      With fewer recalls than conventional foods, drugs, animal products and medical devices, supplements could be considered the safest class of goods FDA regulates.
      By Michael McGuffin, President, American Herbal Products Association (AHPA) 06.02.22

    • Breaking News | Dietary Supplements | Functional Foods & Beverages | Industry & Market News | Mergers & Acquisitions | World Markets
      DSM and Firmenich to Merge to Create Nutrition, Beauty, and Wellness Brand

      DSM and Firmenich to Merge to Create Nutrition, Beauty, and Wellness Brand

      The combined company’s global footprint will provide customers with both of the partners’ network of R&D, creation, and application capabilities.
      05.31.22

    Loading, Please Wait..
    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Breaking News
    • Pharmavite Expands in Ohio with $200 Million Investment
    • Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    • Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    • NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon
    • Kensing Acquires Vitae Naturals
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
    Emmanuelle Bromet Named Arkema Sustainable Development VP
    ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—July 2
    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    Pancryos Forges License Agreement for Microencapsulation Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bayer Opens New Research and Innovation Center at Kendall Square
    Lonza Names Maria Soler Nunez as Head, Group Operations
    Eurofins DiscoverX Opens Shanghai Office
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
    Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
    Latest Updates About Cosmoprof North America
    Happi

    Latest Breaking News From Happi

    SCOTUS EPA Ruling Won’t Impact General Regulatory Authority
    Toning Collection For Zero-Brass Blondes is New at Colorproof
    Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Flint OPS, Xerox and MNYPIA Top This Week’s News
    Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
    International Paper Publishes 2021 Sustainability Report
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac boosts operations in US, All4Labels returns to HP and more
    Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
    CELAB Europe wins Paper Recycling award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter, Blue Ocean Closures Partner with Absolut
    What You’re Reading on Nonwovens-Industry.com
    Daio, Livedo Partner to Recycle Diapers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—July 2
    NuVasive Inc. Opens Singapore Experience Center
    Pedicle Screw Systems Market to Top $3B in 2027
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Identiv, and Japan Display Top This Week’s Stories
    Epishine is Building a New Solar Cell Factory in Linköping, Sweden
    Toppan Establishes CVC Fund and Investment Management Company in the US

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login